Search research articles
Contact Us
Filters
Showing results (391-400 of 424) with videos related to
Page
of 43
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study
V K Israel, C Jiang, F M Muggia, et al.
Cancer Treatment Reports
|
January 1, 1979
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474)
D F Chiuten, J M Bennett, R H Creech, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1991
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts
I Gill, F M Muggia, P M Terheggen, et al.
Anti-Cancer Drugs
|
April 8, 2003
Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies
Missak Haigentz, Mimi Kim, Joan Sorich, et al.
Cancer Treatment Reports
|
July 1, 1978
Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26
N M Gad-el-Mawla, F M Muggia, M R Hamza, et al.
Der Unfallchirurg
|
June 1, 1993
[Primary management of polytrauma. Comparison of a German and American air rescue unit]
U Schmidt, M Muggia-Sullam, M Holch, et al.
Cancer Clinical Trials
|
January 1, 1981
Animal toxicology for early clinical trials with anticancer agents
M Rozencweig, D D Von Hoff, M J Staquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study
F M Muggia, P S Braly, M F Brady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1989
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group
N Petrelli, H O Douglass, L Herrera, et al.
Journal of Biological Response Modifiers
|
August 1, 1988
Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide
R L Krigel, C M Slywotzky, M Lonberg, et al.
Page
of 43
Search research articles
Search
Showing results (391-400 of 424) with videos related to
Sort By:
Page
of 43
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study
V K Israel, C Jiang, F M Muggia, et al.
Cancer Treatment Reports
|
January 1, 1979
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474)
D F Chiuten, J M Bennett, R H Creech, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1991
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts
I Gill, F M Muggia, P M Terheggen, et al.
Anti-Cancer Drugs
|
April 8, 2003
Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies
Missak Haigentz, Mimi Kim, Joan Sorich, et al.
Cancer Treatment Reports
|
July 1, 1978
Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26
N M Gad-el-Mawla, F M Muggia, M R Hamza, et al.
Der Unfallchirurg
|
June 1, 1993
[Primary management of polytrauma. Comparison of a German and American air rescue unit]
U Schmidt, M Muggia-Sullam, M Holch, et al.
Cancer Clinical Trials
|
January 1, 1981
Animal toxicology for early clinical trials with anticancer agents
M Rozencweig, D D Von Hoff, M J Staquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study
F M Muggia, P S Braly, M F Brady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1989
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group
N Petrelli, H O Douglass, L Herrera, et al.
Journal of Biological Response Modifiers
|
August 1, 1988
Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide
R L Krigel, C M Slywotzky, M Lonberg, et al.
Page
of 43